Biocytin

CAS No.:576-19-2

TBW04248
Biocytin;N6-[5-[(3aS,4S,6aR)-Hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl]-1-oxopentyl]-L-lysine;(2S)-6-[5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]-2-aminohexanoic acid;Biocytin​;H-L-Lys(Biotinyl)-OH;H-Lys(biotinyl)-OH;H-Lys(biotinyl)-OH(Biocytin);N'-Biotinyl-L-lysine;(S)-(-)-Pindolol;Bct,Nε-(+)-Biotinyl-L-lysine;Biotinyl-L-lysine;N6-[5-((3aS)-2-oxo-(3ar,6ac)-hexahydro-thieno[3,4-d]imidazol-4t-yl)-pentanoyl]-L-lysine;N6-[5-((3aS)-2-oxo-(3ar,6ac)-hexahydro-thieno[3,4-d]imidazol-4t-yl)-valeryl]-L-lysine;N6-D-Biotinyl-L-lysine;Ne-Biotynyl-L-lysine;Bct;Nε-(+)-Biotinyl-L-lysine;(+)-Biocytin;C16H28N4O4S;epsilon-N-Biotinyl-L-lysine;G6D6147J22;n6-{5-[(3as,4s,6ar)-2-oxohexahydro-1h-thieno[3,4-d]imidazol-4-yl]pentanoyl}-l-lysine;(2S)-6-{5-[(3aS,4S,6aR)-2-oxo-hexahydro-1H-thieno[3,4-d]imidazolidin-4-yl]pentanamido}-2-aminohexanoic acid;biotinyllysin;N6-(;(2S)-6-{5-[(3aS,4S,6aR)-2-oxo-hexahydro-1H-thieno[3,4-d]imidazol-4-yl]pentanamido}-2-aminohexanoic acid;N6-[5-[(3aS,4S,6aR)-Hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl]-1-oxopentyl]-L-Lysine;.epsilon.-N-Biotinyl-L-lysine;AKOS015915827;HY-101884;DTXSID30973172;DS-5744;CHEBI:27870;Biocytin (epsilon;-Biotinoyl-L-lysine);(3aS-(3aalpha,4beta,6aalpha))-N(6)-(5-(hexahydro-2-oxo-1H-thieno(3,4-d)imidazol-4-yl)-1-oxopentyl)-L-lysine;N6-delta-Biotinyl-L-lysine;(S)-2-amino-6-(5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamido)hexanoic acid;BIOCYTIN [MI];Q864247;L-Lysine, N6-(5-(hexahydro-2-oxo-1H-thieno(3,4-d)imidazol-4-yl)-1-oxopentyl)-, (3aS-(3aalpha,4beta,6aalpha))-;N(epsilon)-biotinyl-L-lysine;SCHEMBL305707;N-biotinyl-L-lysine;Biocytin, >=98% (TLC);L-Lysine,N6-[5-[(3aS,4S,6aR)-hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl]-1-oxopentyl]-;576-19-2;HB5035;N6-BIOTINYLLYSINE;N(6)-D-biotinyl-L-lysine;BAQMYDQNMFBZNA-MNXVOIDGSA-N;UNII-G6D6147J22;s9886;A869630;MFCD00077319;N-epsilon-Biotin-L-lysine;N~6~-{5-[(3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl]pentanoyl}-L-lysine;N6-(5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanoyl)-L-lysine;N(SUP 6)-(5-((3AS,4S,6AR)-HEXAHYDRO-2-OXO-1H-THIENO(3,4-D)IMIDAZOL-4-YL)-1-OXOPENTYL)-L-LYSINE;BP-23273;epsilon-N-biotinyllysine;L-Lysine, N6-(5-((3aS,4S,6aR)-hexahydro-2-oxo-1H-thieno(3,4-d)imidazol-4-yl)-1-oxopentyl)-;N(6)-{5-[(3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl]pentanoyl}-L-lysine;CS-7587
inquiry
C16H28N4O4S
372.48

Product introduction

Category: Drug Impurities and Intermediates
Appearance: powder
Purity: 95~98%(HPLC)
Storage conditions: -20°C under seal save, placed in ventilated, dry environment
Application: All our products are for research and lab only. Injecting, eating and other ways are forbidden.
Package: 5mg,10mg ,20mg ,50mg ,100mg,1g, 100g or customized
SMILES: S1C([H])([H])[C@@]2([H])[C@@]([H])([C@]1([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C(N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[C@@]([H])(C(=O)O[H])N([H])[H])=O)N([H])C(N2[H])=O